2022 Volume 22 Issue 3 Pages 121-126
Biomolecules such as proteins or nucleic acids have been utilized as biopharmaceutical drugs, which produce various pharmacological activities. The development of a novel transdermal delivery system of biopharmaceuticals attracts much attention because it provides the easy and safe administration method compared to injection. The Solid-in-Oil (S/O) nanodispersion technique consists of the oil-based dispersion, in which the biopharmaceuticals are coated with hydrophobic surfactant molecules and dispersed in the oil phase as nanometer-sized particles. Insulin, a model pharmaceutical drug, enables to be dispersed in isopropyl myristate (IPM), that is known to be an effective skin penetration enhancer, by forming the S/O nanodispersion. The permeability of insulin into the skin was drastically enhanced. Further, the transdermal vaccination has been studied as one of the most important applications of the S/O nanodispersion. It was proved that the S/O nanodispersion containig a model antigen produced the antigen-specific antibodies and induced the cytotoxic cellular immunity in mouse. These results suggested that the S/O nanodispersion technique is useful for delivering biopharmaceuticals into the skin, and expected to become available in clinical.